Major “GO” signal just appeared on this stock

This is my favorite type of trading setup *Sponsored by Sica Media The markets are rocking once again today. Things are looking a little extended in the short-term, but I was right once again in calling the reversal last week. Today, I am starting to take chips off of the table and looking for opportunities that others are missing. I don’t see many setups better than what I am seeing with NLS Pharmaceuticals (NLSP) right now. I know it is a small, $.70 stock, but that is exactly what I am drawn to. Those are the types of stocks that can make incredible percentage gain moves in a very short period of time. Just this morning, we already saw NLSP make a nearly 10% move in the opening hour after I told you about it. Right now, it is still holding a very respectable 7% gain on the day. Pretty good for people who simply opened an email of mine this morning, but where is it going from here? Well, no one ever knows for sure, but what I do know is that I am seeing one of the strongest indicators in the entire market right now. See this cluster of “GO” signals? When I look at 1000’s of charts, in any timeframe, this is what I typically see before a major trend reversal. And if history holds up, NLSP has had a history of making big, double-digit moves when it decides to reverse course. I would certainly rather be early in a move like rather than waiting on the sidelines and watching it happen without me. If you haven’t taken a look at NLSP today, you still have a few hours left in the day. Who knows where it will be tomorrow? I gave the following baseball analogy this morning. It is how I look for trades that are so obvious, it is stupid not to take a swing. I wait for what I call “fat pitches” to come along — high-confidence moves based on solid technicals. Well, folks, today I see one coming right over the plate. It’s a nice, slow, fat pitch coming your way… all you need to do is get a plan and take a swing. Let me explain… I first wrote to you about Swiss-based NLS Pharmaceutics (NASDAQ: NLSP) in late-August. As I wrote at the time, “We don’t often see setups like these so it is imperative to take full advantage when they do come around.” If you paid attention to that, you then witnessed NLSP make a double-digit move higher over the next week, before consolidating one more time, and ultimately making a clear breakout over 20% higher. Well folks, I’ve stayed tuned to the NLSP story since then and right now my favorite indicators are signaling that we may be on the cusp of another major breakout. Check this out: That’s the analysis of an advanced, computer-generated algorithm that considers over a dozen different momentum indicators to determine the most likely trend going forward. This “go/no go” algorithm is the single-best computer-generated indicator I look to for confirmation on when to enter a trade. When I layer it on top of my own indicators and analysis, it gives me a very high-level of confidence in my personal trading.. As you can see, I’ve highlighted several very quick and sizable recent gains… A 66% move in 4 days… a 40% move in a single day… a 22% move in 2 days… and a 42% move in 5 days… …And this is all just since June! In three of those reversals, you can see multiple, conflicting go/no-go markers along the trendline just before the chart legged up. These mixed signals are a classic indicator I’ve seen play out countless times before reversals. And that brings me to what I am seeing today. Those conflicting go/no-go markers suggest we could be very close to an inflection point, just like when I first alerted you to NLSP on August 22, before it made a 42% move higher. Looking at the chart of the last week, I’m not surprised those markers are flashing: As you can see, by the end of last week, NLSP was trading flat overall, but had tested new highs that were at least 10% moves up throughout the week. Yesterday morning kicked off with yet another 10% spike before settling in at recent support above $.70. This is often what the valley of a reversal will look like. Rarely will a stock rocket straight up at the end of a weeks-long drawdown. Instead, it will test the breakout repeatedly before making its ultimate swing. This is a great indication that an upside move could be coming, and that it could be dramatic. One of the most important items you should read on NLSP right now is the recent [shareholder letter]( their CEO recently issued. On top of the $10M private placement (which should firm up the company’s finances), one of the biggest news items I found that most traders overlooked is this line: “At this time we have received several non-binding term sheets for a potential partnership agreement within the pharmaceutical industry.” Take it how you will, but that sounds to me like NLSP could be very close to securing a game-changing partnership to help get their key product to market. That actually should not be surprising considering since in July of 2023, NLSP announced that the Phase 3 clinical trial (called the AMAZE Program) protocol to evaluate the safety and efficacy of Mazindol ER in patients with narcolepsy type 1 received approval from the independent Institutional Review Board ("IRB"). On top of that, On August 25, 2023, NLSP submitted a fast-track designation application for Mazindol ER for the treatment of narcolepsy to the FDA. That is huge. You see, standard reviews by the FDA for drug approval generally take about one year. A medicine that receives “Fast Track Designation” can be on the market within six months of the regulatory application. Fast-Track approval could literally change the fortunes of NLSP shareholders… overnight. It’s not only my technical analysis that gives NLSP a “thumbs up 👍” right now. As further confirmation, Yahoo! Finance is lighting up “bullish” on the slow stochastic oscillator, which you can read about in detail [here](. In brief, the slow stochastic helps us distinguish signal from noise by comparing the latest closing price to the highs and lows over the last 14 periods. This popular indicator is also giving a green light. Checking the news cycle, we just received [this report]( from Fintel last week: - The average one-year price target for NLS Pharmaceutics (NLSP) has been revised to $9.94 / share. This is an increase of 24.47% from the prior estimate of 7.99 dated August 31, 2023. - The price target is an average of many targets provided by analysts. The latest targets range from a low of 6.06 to a high of 14.18 / share. The average price target represents an increase of 1,286.84% from the latest reported closing price of 0.72 / share. If the analysts are right, the average price target represents a 10-bagger opportunity 💰 Of course, since NLSP is a clinical-stage pharmaceutical company, a lot of that depends on the success of the company’s drug trials… Between the explosive technical setup we are seeing along the the potentially game-changing developments recently, these things could all be catalysts for a serious rocket-ride for the stock 🚀. Will that happen for sure? The future is never certain in the markets. There is always risk. But as I said, based on my analysis, this is looking like a pitch right over the plate. You must do your own research, however. I’m mortal, after all, and I want all my readers to get used to studying charts, examining fundamentals, and ultimately making up their own minds. Nothing is ever guaranteed in life or trading, so make wise decisions that consider your own personal risk profile. I suggest first checking out the NLS Pharmaceutics website [here](, and especially browse through the [“Investors page](”. This is an opportunity that might be gone before you know it, so take the time to learn more about NLSP right now and see if it makes sense for you. From there, you’ll want to do an in-depth study of the stock’s chart. Again, the ticker is NLSP. Happy hunting!To Your Success, *This investment involves substantial risk. Please see full disclosure below, and detailed discussion of risks and atypical results. Full Disclaimer RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Manage your email subscriptions.]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. If you have a current active subscription with Bullseye Trades you will need to contact us if you want to cancel your subscription. Opting out of emails does not remove you from your service at Bullseye Trades.